BackImageneBio Overview

ImageneBio Receivables

Latest receivables for IMA: $2.6M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$2.56M

Peer trimmed avg / median

Loading

ImageneBio Receivables History

Loading

ImageneBio vs. peers: Receivables Comparison

Loading

ImageneBio Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

ImageneBio (IMA) FAQ

ImageneBio (IMA) currently reports a receivables of $2.6M as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore ImageneBio's receivables history and peer comparisons.

ImageneBio's receivables changed from $0 to $2.6M (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ImageneBio reported $2.6M in receivables as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $2.6M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ImageneBio, and consider following IMA for alerts when major investors trade the stock.

ImageneBio is classified in the Healthcare sector. On receivables, it currently shows $2.6M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IMA with unrelated industries.